SPRY Therapeutics is a Pune, India–based SaaS platform serving physical therapy professionals. It offers an AI-driven clinic management solution that automates complex billing tasks, streamlines clinic operations, and enhances patient engagement. The platform focuses on simplifying billing and improving efficiency for physical therapists. The company has partnered with over 105 clinics across 30 US states. SPRY will use the $15M raised to accelerate its expansion in the US market and has now raised $25M in total funding. The company was founded by Brijraj Bhuptani and Riyaz Rehman. Spry offers a full-stack patient and practice management SaaS platform tailored to physical rehabilitation clinics, consolidating clinical and administrative workflows. The platform supports patient intake, scheduling, communication, assessments, electronic medical records (EMR), revenue cycle management, home exercise plans, adherence tracking, and patient lifecycle management. Spry leverages physical rehabilitation–specific workflows, advanced computer vision technology, and modern product design to streamline care delivery, increase patient inflow, and reduce administrative costs. The company was founded in 2021 by Brijraj Bhuptani and Riyaz Rehman and is based in New Jersey. Spry says it aims to democratize accessibility and affordability of movement health through its digital health platform. The company will use new funding to accelerate its mission to build the future of practice management for physical rehabilitation and has raised over $10 million to date. Spry is a communication and assessment SaaS platform built for the movement health and physical therapy market. The company was founded in March 2021 by Brijraj Bhuptani (Ola’s ex‑CTO) and Riyaz Rehman. Its full‑stack digital health platform enables practitioners and owners of physical therapy centers to manage clinical and administrative functions with a single tool. Spry raised a $3.0M Seed round in December 2021. The company plans to use the funds to bolster product development, expand and strengthen its market share in India, and kick‑start its go‑to‑market strategy in the US.

Total raised

$18M

Funding rounds

3

Latest round

Equity

Latest activity

Oct 2024